Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
XSign in

Market Pulse

KIS quote snapshot · Sep 21, 2026 12:30 KST · KIS quote snapshots + ECOS · 30 min refresh
KOSPI
7,011.79
+117.56 (+1.71%)
KOSDAQ
835.45
+8.33 (+1.01%)
KOSPI 200
1,113.23
+23.00 (+2.11%)
USD/KRW
1,383.30
Home›Reports›389650
389650KOSDAQ·Sep 09, 2025

From Hemostasis to Pain Relief, Expanding Technology on a Global Scale(Summary ver.)

NEXTBIOMEDICAL Co., Ltd.Korea IR ServiceEdward Kim

Korea IR Service published a research report on NEXTBIOMEDICAL Co., Ltd. (389650) titled "From Hemostasis to Pain Relief, Expanding Technology on a Global Scale(Summary ver.)".

Summary
Covers NEXTBIOMEDICAL Co., Ltd. (389650).
Covered stock
389650
NEXTBIOMEDICAL Co., Ltd.
KOSDAQ · KIRS research report
Stock page →
KOSDAQ
From Hemostasis to Pain Relief, Expanding Technology on a Global Scale(Summary ver.)
Korea IR Service
NEXTBIOMEDICAL Co., Ltd. logo
Source
Korea IR Service
PDF
Open report PDF →
Report facts
BrokerKorea IR Service
AnalystEdward Kim
Publication dateSep 09, 2025
Rating-
Target price-
CollectedMay 06, 2026
Use the publisher link for the complete report. Korean Tickers shows report metadata and a short overview.
Korean Tickers·Research reference for Korean listed companies.
API overviewPricingDocumentationPlan & billing
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy